Oropharynx Cancer: Clinical Trials

7 trials for Oropharynx Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated, 1 recruiting, 1 unknown. 7 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 2, Terminated 2, Recruiting 1, Unknown 1, Withdrawn 1
Phase 22Completed 1, Recruiting 1

Follow Oropharynx Cancer: new trials by email Literature Review of Oropharynx Cancer trials Research Report on Oropharynx Cancer

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
E7 TCR-T cells, Aldesleukin - HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma
Phase 1 / Phase 2RecruitingChristian Hinrichs152025-08-112026-10-28
A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers
Zimberelimab, Etrumadenant, Cisplatin - Head and Neck Cancer, Squamous Cell Carcinoma of Head and Neck
Phase 1WithdrawnJennifer Choe2023-12-312023-11-30
Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors
TBio-6517, Pembrolizumab - Solid Tumor, Microsatellite Stable Colorectal Cancer
Phase 1TerminatedTurnstone Biologics, Corp.272020-06-022025-04-23
Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth
Allogeneic adipose derived stem/stromal cells - Xerostomia Due to Radiotherapy, Hyposalivation
Phase 1UnknownCopenhagen University Hospital, Rigshospitalet102019-03-182021-01-29
Pembrolizumab in Combination With CRT for LA-SCCHN
pembrolizumab (MK-3475), Cisplatin, Radiation - Head and Neck Cancer, Squamous Cell Carcinoma
Phase 1CompletedSanford Health592015-11-012025-10-07
TPF-Induction Chemotherapy of Oropharyngeal and Cavity of the Mouth Cancer
Taxotere, Cisplatin, 5-Fluorouracil (5-FU) - Oropharynx Cancer, Squamous Cell Carcinoma of the Oral Cavity
Phase 1 / Phase 2CompletedOrlando Guntinas-Lichius, Prof. Dr. med.712009-11-012016-05-18
Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
Motexafin Gadolinium Injection - Head and Neck Cancer, Oropharynx Cancer
Phase 1TerminatedPharmacyclics LLC.182007-05-08

Narrower conditions

Oropharyngeal Neoplasms (7)  ·  Head and Neck Neoplasms (3)  ·  Hypopharyngeal Neoplasms (3)  ·  Laryngeal Neoplasms (3)  ·  Mouth Neoplasms (2)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Uterine Cervical Neoplasms (2)  ·  Anus Neoplasms (1)  ·  Carcinoma, Renal Cell (1)  ·  Carcinoma, Squamous Cell (1)  ·  Laryngeal Diseases (1)  ·  Melanoma (1)  ·  Mesothelioma (1)  ·  Penile Neoplasms (1)  ·  Pharyngeal Neoplasms (1)

Broader conditions

Neoplasms (7)  ·  Neoplasms by Site (7)  ·  Otorhinolaryngologic Diseases (7)  ·  Otorhinolaryngologic Neoplasms (7)  ·  Pharyngeal Diseases (7)  ·  Stomatognathic Diseases (7)  ·  Pharyngeal Neoplasms (6)  ·  Carcinoma (4)  ·  Head and Neck Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Mouth Diseases (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Neoplasms (3)  ·  Carcinoma, Squamous Cell (2)

Interventions

Cisplatin (3)  ·  Radiation (2)  ·  pembrolizumab (2)  ·  Adoptive Transfer (1)  ·  Docetaxel (1)  ·  Fluorouracil (1)  ·  aldesleukin (1)  ·  motexafin gadolinium (1)  ·  zimberelimab (1)

Sponsors

Christian Hinrichs (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Jennifer Choe (1)  ·  Orlando Guntinas-Lichius, Prof. Dr. med. (1)  ·  Pharmacyclics LLC. (1)  ·  Sanford Health (1)  ·  Turnstone Biologics, Corp. (1)

Countries

United States (4)  ·  Canada (1)  ·  Denmark (1)  ·  Germany (1)  ·  South Korea (1)

Top investigators

Charlotte Lynggaard, MD (1)  ·  Christian S Hinrichs, MD (1)  ·  Ines Verdon, MD (1)  ·  Jennifer Choe, MD, PhD (1)  ·  Orlando Guntinas-Lichius, Prof. Dr. (1)  ·  Steven F Powell, MD (1)

Results publications

PMID 23083061, PMID 26186556, PMID 28498880, PMID 32479189

NIH funding

2009 (1), 2018 (1)